Journal ArticleOPEN ACCESS

The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study

International Journal of Dermatology (2026) 65(2) 356-358
DOI: 10.1111/ijd.17923
0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Mruwat, N., Givon-Lavi, N., Ludwig, R. J., & Kridin, K. (2026). The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study. International Journal of Dermatology, 65(2), 356–358. https://doi.org/10.1111/ijd.17923

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free